DASATINIB Teva cpr pell 70 mg 60 pce
7680671000139
CH-67100
L01EA02
07.16.1.
Reimbursement limitations:
SPRYCEL2
Ce dosage est exclu pour le traitement de patients souffrant de leucémie myéloïde chronique à …
1 / 3
google
Details
- Product number
- 6710003
- CPT
- -
- Packaging group
- 60
- Unit
- Tablette(n)
- Composition
- dasatinibum 70 mg ut dasatinibum monohydricum, lactosum monohydricum 91.915 mg, cellulosum microcristallinum, hydroxypropylcellulosum, carmellosum natricum conexum corresp. natrium max. 1.01 mg, magnesii stearas, Überzug: hypromellosum, triacetinum, E 171, pro compresso.
Articles (1)
Dasatinib-Teva 70 mg, Filmtabletten
Filmtabletten
60
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
70.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
91.915 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FNIDK |
Reimbursement information
Public price
CHF 1183.10
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/12/2022
Authorization holder
Teva Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 67100
- Drug name
- Dasatinib-Teva, Filmtabletten
- Galenic form
- FILM
- ATC Code
- L01EA02
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 03/05/2019
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- DASATINIB Teva cpr pell 70 mg 60 pce
- Description (DE)
- DASATINIB Teva Filmtabl 70 mg 60 Stk
- Market launch
- 03/05/2019
- Narcotic (BTM)
- No